US Drug Recall Register
Class III · Low risk Terminated Initiated May 2, 2016 (10 years ago)

Dicloxacillin Sodium Capsules USP

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.

What was recalled

Dicloxacillin Sodium Capsules USP, 500mg, Rx Only, 100 Capsule bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz Inc. , Princeton, NJ 08540, Product of Spain, NDC 0781-2258-01

Recalling firm
Sandoz, Inc
NDC code
0781-2258-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1046-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Oxacillin recalls

See all
Class II · Moderate risk Ongoing

Oxacillin for Injection

Reason Lack of Assurance of Sterility

Sagent Pharmaceuticals NDC 25021-163-99 D-0937-2023
Class II · Moderate risk Ongoing

Oxacillin for Injection

Reason Lack of Assurance of Sterility

Sagent Pharmaceuticals NDC 25021-162-24 D-0936-2023
Class II · Moderate risk Ongoing

Oxacillin for Injection

Reason Lack of Assurance of Sterility

Sagent Pharmaceuticals NDC 25021-146-10 D-0935-2023
Class II · Moderate risk Terminated

Oxacillin for Injection

Reason Presence of Particulate Matter; The firm received two product complaints for small, dark particulate matter identified in solution post reconstitution.

Sagent Pharmaceuticals Inc NDC 25021-163-69 D-1450-2016
Class III · Low risk Terminated

Dicloxacillin Sodium Capsules

Reason Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.

Sandoz, Inc NDC 0781-2248-01 D-1045-2016